StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Nu-Med Plus's ebitda for the twelve months ending Dec 31, 2022 was -$179.90K. For fiscal 2022 it was -$179.90K. The highest annual figure on record is -$179.90K in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$179.90K–
FY2021Dec 31, 2021-$830.08K–
FY2020Dec 31, 2020-$1.98M–
FY2019Dec 31, 2019-$1.01M–
FY2018Dec 31, 2018-$1.15M–
FY2017Dec 31, 2017-$453.98K–
FY2016Dec 31, 2016-$1.22M–
FY2015Dec 31, 2015-$939.33K–
FY2014Dec 31, 2014-$1.14M–
FY2013Dec 31, 2013-$230.44K–
FY2012Dec 31, 2012-$256.41K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-$6.39K–
Q3 FY2022Sep 30, 2022-$58.02K–
Q2 FY2022Jun 30, 2022-$57.85K–
Q1 FY2022Mar 31, 2022-$57.64K–
Q4 FY2021Dec 31, 2021-$109.69K–
Q3 FY2021Sep 30, 2021-$115.72K–
Q2 FY2021Jun 30, 2021-$250.57K–
Q1 FY2021Mar 31, 2021-$354.10K–
Q4 FY2020Dec 31, 2020-$488.51K–
Q3 FY2020Sep 30, 2020-$446.71K–
Q2 FY2020Jun 30, 2020-$901.40K–
Q1 FY2020Mar 31, 2020-$146.27K–
Q4 FY2019Dec 31, 2019-$202.67K–
Q3 FY2019Sep 30, 2019-$143.08K–
Q2 FY2019Jun 30, 2019-$240.36K–
Q1 FY2019Mar 31, 2019-$419.95K–
Q4 FY2018Dec 31, 2018-$332.19K–
Q3 FY2018Sep 30, 2018-$518.49K–
Q2 FY2018Jun 30, 2018-$164.91K–
Q1 FY2018Mar 31, 2018-$138.98K–
Q2 FY2017Jun 30, 2017-$107.72K–
Q1 FY2017Mar 31, 2017-$67.94K–

More Nu-Med Plus figures

See a number that looks wrong?